Company overview

By integrating innovation, quality and accessibility, we improve health worldwide like no one else.

Established over 100 years ago in 1901, Teva’s global headquarters is based in Israel. We have a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities.

Today, Teva ranks among the 10 top pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission.

Teva Pharma Australia Pty Ltd was established in August 2014. Teva is unique as the only major pharmaceutical company in Australia to conduct cutting-edge biologic drug discovery, design and pre-clinical development in Australia in a dedicated biologics R&D facility. Our headquarters in Macquarie Park, Sydney houses both the research labs as well as the pharmaceutical headquarters. Our global strength in generic medicines, innovative and speciality pharmaceuticals is set to deliver an important contribution to Australia and Australians.

 

Teva is committed to increasing access to high-quality healthcare for people across the globe, at every stage of life. We do this by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. This is backed by our impressive global development and manufacturing capabilities, ensuring the highest quality and accessibility to medicines while reducing costs. Teva’s participation in a wide range of therapeutic areas and dosage forms is empowered by a unique integration of innovative specialty and generic research.